Strategic Technologies for Europe Platform (STEP)

European Parliament Publishes Study On Chinese Industrial Overcapacity In Key Green-Tech Sectors

The European Parliament has released a strategic analysis of Chinese industrial overcapacity across the battery, hydrogen, semiconductor, and robotics sectors. This signals a shift toward more assertive EU trade-defense measures and protectionist industrial policies aimed at securing domestic green-tech supply chains and reducing reliance on Chinese imports.

2 Apr 2026, 17:46europarl.europa.euEuropean Union

Commission Approves €500 Million Luxembourg Cleantech Manufacturing State Aid Scheme

The European Commission has approved a 500 million euro Luxembourgish state aid scheme to accelerate the expansion of domestic clean technology manufacturing capacity. This initiative offers significant capital incentives for companies scaling green industrial operations and signals a broader EU commitment to reshoring strategic cleantech supply chains.

29 Mar 2026, 06:09ec.europa.euEuropean UnionLuxembourg

EU Commission Answer Clarifies Chips Act 2 Scope for Printed Circuit Boards and Refers to Cybersecurity Act 2

The European Commission confirmed printed circuit boards are in scope for the upcoming Chips Act 2 and introduced new ICT supply chain security mandates under the proposed Cybersecurity Act 2. Electronics manufacturers should anticipate expanded investment incentives alongside stricter vetting requirements for components and services sourced from high-risk third-country suppliers.

26 Mar 2026, 19:23europarl.europa.euEuropean Union

EU Proposes Council Decision on Signing and Provisional Application of EU–Japan Agreement for Participation in Union Programmes (Horizon Europe Pillar II)

The EU has proposed a formal agreement to associate Japan with Horizon Europe Pillar II, enabling Japanese entities to participate in collaborative research calls starting retroactively from January 2026. This partnership strengthens R&D ties in strategic industrial and sustainability sectors, offering expanded opportunities for cross-border innovation and joint funding in global challenge areas.

24 Mar 2026, 11:41eur-lex.europa.euEuropean UnionJapan

European Commission Lists Biotech Act II as Planned Initiative

The European Commission has formally scheduled the Biotech Act II as a cornerstone of its 2026 regulatory agenda for the Single Market. This initiative signals a strategic shift toward harmonizing the EU bioeconomy, requiring firms to prepare for new frameworks governing market access and industrial competitiveness.

22 Mar 2026, 13:29ec.europa.euEuropean Union

EU Parliament ENVI/SANT Committees To Consider Biotechnology Act Proposal On GMMs And Organ Processing

EU Parliament committees will review proposals to modernize biotechnology rules for genetically modified micro-organisms and organ processing in March 2026. The shift toward simplified authorizations and unlimited market consent for GMMs signals a more streamlined regulatory environment for biotech innovation and market access.

19 Mar 2026, 12:42europarl.europa.euEuropean Union

EU Commission Grants Open EU Foundry Status to 'Project Vulcan' Under Chips Act

The European Commission has formally designated Project Vulcan as an open EU foundry, marking a significant expansion of domestic semiconductor manufacturing capacity under the EU Chips Act. This designation provides the project with strategic priority and streamlined permitting, strengthening the regional supply chain and reducing reliance on external chip production.

14 Mar 2026, 08:01ec.europa.euEuropean Union

EU Parliament Public Health Committee Draft Agenda: Votes on EU Pharmaceutical Package and European Biotech Act (18–19 March 2026)

The European Parliament's SANT Committee will vote on the EU Pharmaceutical Package and review the European Biotech Act on March 18–19, 2026. This marks a decisive step toward a comprehensive regulatory overhaul of market authorization, supply chain resilience, and safety standards for the life sciences sector.

13 Mar 2026, 10:50europarl.europa.euEuropean Union

EU Parliament SANT–ITRE Committees Schedule European Biotech Act Presentation For 19 March 2026

EU Parliament committees will review the proposed European Biotech Act in March 2026 to modernize and streamline regulatory frameworks for biotechnology and biomanufacturing. This initiative signals a strategic shift toward accelerated market access and simplified compliance pathways for health, food, and veterinary sectors to boost industrial competitiveness.

13 Mar 2026, 08:37europarl.europa.euEuropean Union

EU Parliament SANT Committee To Review Negotiations on Critical Medicinal Products Proposal

The European Parliament is advancing negotiations on a new framework to secure the supply and availability of critical medicinal products. This signals increasing legislative momentum toward mandatory supply chain resilience and shortage mitigation requirements for pharmaceutical operators.

13 Mar 2026, 08:37europarl.europa.euEuropean Union

EU Council Prepares Trilogues on Critical Medicines Act Proposal

The EU is advancing the Critical Medicines Act toward final adoption to strengthen pharmaceutical supply chains and industrial resilience. Companies should prepare for non-price procurement criteria and potential obligations for strategic stockpiling and EU-based production to secure market positioning.

11 Mar 2026, 17:27eur-lex.europa.euEuropean Union

Denmark Launches DKK 100 Million Fund For Biosolutions Facilities

Denmark has launched a DKK 100 million funding pool to scale biosolutions infrastructure, including microalgae production and microbial fermentation facilities. This investment, paired with Danish advocacy for streamlined EU approvals, signals a strategic shift toward accelerating market entry for novel bio-based products and industrial biotechnology.

6 Mar 2026, 11:17em.dkDenmarkEuropean Union

European Commission Proposes EU Science Diplomacy Framework And Publishes Research Security Monitor 2025

The European Commission has launched a new science diplomacy framework and research security package to align international innovation partnerships with the blocs strategic interests. Organizations should anticipate tighter oversight of cross-border technology transfers and research collaborations as the EU formalizes its approach to managing dual-use risks and geopolitical security.

5 Mar 2026, 09:17research-and-innovation.ec.europa.euEuropean Union

EU Parliament Research Service Analyses Quantum Technologies for Decarbonisation Ahead of Forthcoming Quantum Act

The European Commission is preparing a Quantum Act for Q2 2026 to leverage quantum computing and sensing for industrial decarbonization and material discovery. This initiative signals a strategic shift toward quantum-accelerated R&D, creating new opportunities for innovation in advanced materials, energy storage, and environmental monitoring.

25 Feb 2026, 19:36europarl.europa.euEuropean Union

European Parliament REGI Committee Issues Draft Opinion on European Competitiveness Fund Proposal

The European Parliament's REGI Committee has issued a draft opinion on the proposed European Competitiveness Fund, prioritizing regional cohesion and decarbonization for the 2028 to 2034 period. This fund will serve as a primary vehicle for industrial subsidies and transition financing, shaping the investment landscape for regional innovation and renewable energy infrastructure.

25 Feb 2026, 19:30europarl.europa.euEuropean Union

EU Council Amends Assessment of Lithuania's Recovery and Resilience Plan Under RRF Regulation

The EU Council approved Lithuania's amended Recovery and Resilience Plan, reallocating funds to address supply chain constraints and technical implementation hurdles. This shift prioritizes high-impact investments in renewable energy and zero-emission transport, signaling a more pragmatic approach to achieving national sustainability targets.

12 Feb 2026, 18:35data.consilium.europa.euEuropean UnionLithuania

EU Council Schedules Working Party Meeting on European Biotech Act and GMM Directive Proposal

EU Council working groups are initiating formal discussions on the European Biotech Act and revised rules for genetically modified micro-organisms in early 2026. This legislative push aims to streamline biomanufacturing approvals and market access, requiring life sciences firms to prepare for a more centralized and modernized regulatory framework.

9 Feb 2026, 19:07data.consilium.europa.euEuropean Union

EU Council Consolidates European Biotech Act Amendments to Key Health Regulations

The EU Council has consolidated proposed amendments to major health and biotech regulations under the emerging European Biotech Act framework. This development signals a more integrated regulatory environment for biomanufacturing and clinical trials, requiring life sciences and food tech firms to prepare for streamlined but evolving compliance pathways.

30 Jan 2026, 18:53data.consilium.europa.euEuropean Union

EU Proposal To Amend GMO And Human Organ Directives For Placing Genetically Modified Micro‑Organisms On The Market

The European Union has proposed a Directive to modernize the regulatory framework for placing genetically modified micro-organisms on the market. Businesses should prepare for updated risk assessment and authorization requirements as the EU seeks to streamline biotech commercialization and medical applications.

24 Jan 2026, 09:08members.wto.orgEuropean Union

EU Committee of the Regions Adopts Opinion on Critical Medicines Act Proposal

The European Committee of the Regions has formally endorsed the Critical Medicines Act, prioritizing EU-based production and supply chain resilience. This signals a shift toward mandatory supply transparency and potential reshoring requirements that will reshape pharmaceutical investment and operational risk management.

14 Jan 2026, 11:17data.consilium.europa.euEuropean Union